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Abstract
The aim of this study was to assess the fatty acid balance in the blood plasma, in the fragments of the intact vessels and the 
vessels showing signs of atherosclerosis. Material and Methods: The article presents the results of the examination of the blood 
plasma samples of patients with coronary heart disease and coronary atherosclerosis. The control group consisted of 16 healthy 
individuals.  Also, the fragments of the abdominal aorta and the common carotid artery with varying degrees of atherosclerotic 
lesions were studied. Fatty acid analysis was conducted using capillary gas-liquid chromatography. Results: A reduction in the 
relative linoleic acid level with an increase in almost all the saturated fatty acids and polyunsaturated dihomo-γ-linolenic acid in the 
plasma was noted in patients with coronary heart disease and atherosclerosis. The relationships between certain fatty acids in patients 
with atherosclerosis and myocardial ischemia showed changes. In patients with atherosclerosis, a marked imbalance was observed 
between the monounsaturated and correspondingly the saturated fatty acids (with the same number of carbon atoms) in the abdominal 
aorta with significant atherosclerotic lesions, as well as in the intact common carotid arteries. These disorders are probably related to 
the relatively low content of the linoleic acid in the blood plasma. The reasons for the increased activity of the fatty acid synthase in 
vessels with significant atherosclerotic lesions are described. It is concluded that most of the fatty acids of the plaque were formed 
due to the synthetic processes in the smooth muscle cells, and not as a result of their intake from the blood plasma. 
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Introduction
For many years, there has been a great interest in the 
problem of lipid accumulation in the arterial wall in patients with 
atherosclerosis. However, some aspects of the atherosclerotic 
lesions of the vessels and causes of dyslipidemia remain unclear 
[1,2]. Questions related to the role of the individual fatty acids 
(FA), including polyunsaturated FA (PUFA), in the development 
of atherosclerosis warrant further research. 
It has been shown that cholesterol (as well as compounds 
possessing fatty acid) is the predominant lipid of the 
atherosclerotic plaques (AP) [3]. It is accepted that cholesterol 
almost wholly enters from the blood as a component of 
lipoproteins, and is not a result of local synthesis [4].  However, 
a study of the lipids in the AP and lipid spots revealed that the 
plaques contain significantly more free cholesterol relative to 
the cholesterol esters (CE) [3]. This fact opposes the concept of 
the origin of the atheromatous lipids from the plasma, as most 
part of the plasma cholesterol is represented by the CE [5]. The 
mechanism of the lipid penetration through the fibrous cap of 
the plaque remains unclear. According to one theory, the AP 
growth is due to the lipid accumulation coming from the vessels 
growing into the plaque [6]. However, it has been shown that the 
cells of the arteries synthesize the FA de novo, and that the FA 
are synthesized in greater quantity in the atherosclerotic arteries 
than in the intact arteries [7]. 
Thus, although the study of atherosclerosis is the subject 
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of numerous publications [1-7], to date, several questions 
still remain unanswered regarding the different stages of 
atherogenesis that warrant further study. Also, the recent data 
recorded  on  the  metabolism  of  the  fibrous  plaque  are  still 
insufficient. 
The aim of this study was to assess the fatty acid balance 
in the blood plasma, in the fragments of the intact vessels and 
the vessels showing signs of atherosclerosis.
Material and Methods
   The objects in this study were fragments (weight 2-3 
g) of the abdominal aorta and the common carotid artery from 
the dead bodies of nine men (average age at death was 50 ± 6.7 
years).  Also, 3-4 mL of blood was taken from each corpse.
It was shown [8] that the AP was most often localized 
in the wall of the abdominal aorta. The common carotid artery 
showed more resistance to atherosclerotic lesions. In this work, 
all the samples of the common carotid artery studied showed no 
atheromatous changes. All the samples of the abdominal aorta 
had varying degrees of atherosclerotic lesions.  Six of them 
revealed the 4th type (control), three showed the 5-6th type of 
atherosclerotic lesions (experimental group). The atherosclerotic 
lesions were assessed based on the classification developed by 
H.C. Stary [8].
 The blood plasma samples of 16 patients (57.1 ± 1.4 years) 
with coronary heart disease (CHD), coronary atherosclerosis, 
angina II-III functional class, and hypertension were studied. 
The blood plasma samples of 16 healthy volunteers served as 
the control (37.7 ± 3.2 years). 
As an adequate model of atherosclerosis cannot be 
obtained in rats with high-cholesterol diets [9], we examined the 
FAs present in the blood plasma of 20 rats and in the abdominal 
aorta of 4 rats.
 The preanalytical phase of the study involved the isolation 
of the cellular component of the plasma by centrifugation. To 
obtain the ethyl esters of the fatty acids of the plasma lipids, 
derivatization was performed in 1.5 M HCL in ethanol at a 
temperature of 60 º C for 1 hour.  The ethyl esters of the fatty 
acids thus obtained were extracted from the reaction mixture 
using hexane. The fatty acid derivatives of the blood vessels 
were obtained after lipid extraction from the homogenized 
samples using ethanol. Next, homogenization of the blood vessel 
fragments was performed, until smooth. They were first ground 
with a porcelain pestle in a mortar with ground glass and a small 
amount of ethanol. Similarly, acidic ethanolysis was done and 
the ethyl esters of the fatty acids were extracted using hexane. 
To analyze the FA in the hexane extracts, gas-liquid 
chromatography was employed and registration of the identified 
chemical compounds was done using a flame ionization detector 
[10]. The measurements were done on the gas chromatograph 
GC-1000, Tsvet-800 (Russia). Separation of the analytes was 
performed using a capillary column 60 m in length and 0.56 
mm inner diameter with a silicone stationary phase (SE-30), 
and a 0.25 micron sorbent membrane thickness. Nitrogen was 
used as the carrier gas. Chromatographic conditions included 
injector temperature 280°C, detector temperature 290°C, carrier 
gas consumption at 60 cm³/min and partition coefficient of the 
carrier gas flow 1:12. The chromatograms were produced by 
using the nonlinear heating program of the column thermostat. 
In the first stage, separation was performed for 30 minutes under 
isothermal conditions at 150°C. Then the temperature of the 
column thermostat was raised in several stages (2 to 4 deg/min) 
to 260°C. 
Final  identification  of  the  analytes  was  done  by  using 
chromatography-mass spectrometry method. To achieve this we 
used a gas chromatograph/mass-spectrometer Finnigan DSQ 
II (USA) equipped with a similar chromatographic capillary 
column. Ionization mode: 70 eV. 
Quantitative assessment of the content of the individual 
fatty acids was performed by the normalization method (a peak 
on the chromatogram corresponded to a specific FA and was 
determined as a percentage of the total area of the peaks of all 
the fatty acids). The content of each FA matched to its weight 
percentage of the total amount of FA.
All the data was processed employing the variation 
statistics  methods  using  the  software  Microsoft  Office Word 
Excel 2007, Statistica 8. Analysis of the distribution of the 
values     obtained was performed using the Kolmogorov-Smirnov 
test and Shapiro-Wilk test. The mean (M) and standard error of 
the mean (m), confidence intervals were deduced. The Mann-
Whitney (U Test) was used to compare the differences between 
the two independent groups (for nonparametric data). Pearson’s 
Correlation Coefficient (r) was used to determine the strength of 
the relationship between the two continuous variables. P value 
less than 0.05 was considered significant. 
The study was conducted in accordance with the standards 
of Good Clinical Practice, the principles of the Declaration of 
Helsinki, and with minimal invasive procedures for the subjects. 
Result and Discussion
The analysis of the FA composition in the carotid arteries 
and abdominal aortas showed that the relative content of the 
arachidonic acid in the walls of the common carotid arteries was 
significantly lower than in the fragments of the abdominal aortas 
of the corresponding dead bodies (0.37±0.17% vs 0.84±0.31%,   
p<0.05) regardless of the extent of damage. The arachidonic acid 
levels in the aortas with advanced atherosclerotic lesions had 
a tendency to increase when compared with the aortas without 
major defects (Table 1). Thus, in the vessels with atherosclerosis, 
increasing of the PUFA predisposed to peroxidation was marked.  
This could indicate their higher susceptibility to oxidative 
degradation.
Table 1
Fatty acid composition of the abdominal aorta and the carotid artery 
Fatty acids Control Experiment
(wt% of the 
total FA)
Carotid 
artery
Abdominal 
aorta
Carotid 
artery
Abdominal 
aorta
Lauric 0.34±0.14 0.39±0.28 0.36±0.08 0.55±0.14
Myristoleic 0.19±0.05 0.19±0.07 0.33±0.06* 0.46±0.07*
Myristic 2.72±0.53 2.83±0.81 2.85±0.57 3.70±0.46
Palmitoleic 5.75±1.36 5.34±1.25 7.92±0.81* 9.40±2.57*
Palmitic 26.55±2.11 27.41±2.49 22.40±2.35* 23.29±2.48*
Linoleic 10.27±3.75 10.22±1.86 11.44±4.52 12.27±4.14
Oleic 42.82±2.05 40.55±5.04 44.04±0.64 40.34±0.43
Stearic 6.89±1.14 7.96±2.17 5.31±0.62* 4.76±1.78*
Arachidonic 0.24±0.19 0.73±0.54 0.63±0.28 1.07±0.52
Arachidic 0.89±0.30 0.94±0.36 0.73±0.04 0.58±0.09*
Docosahexaenoic 0.19±0.18 0.29±0.25 0.32±0.20 0.24±0.02
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Fragments of the aortas in the experimental group were 
also characterized by a reduction of the ratio of the saturated 
FA to the monounsaturated acids (MUFA) with the same 
number of carbon atoms (Fig. 1). This ratio was also lower in 
the carotid arteries of the experimental group than the control 
group, although they showed no signs of atherosclerosis. 
The ratio of the saturated FA to the MUFA in the aortas of 
the experimental and the control groups were 8.04 and 14.89 
(p<0.05)  respectively for myristic and myristoleic acids; 2.48 
and 5.13 (p<0.05) for palmitic and palmitoleic, and 0.12 and 
0.2 (p<0.05) for stearic and oleic acid;  in the common carotid 
arteries : 8.64 and 14.32 (p<0.05), 2.83 and 4.62 (p<0.05). 0.12 
and 0.16 (p<0.05) respectively.
Figure 1.
Chromatogram of the saturated and the monounsaturated FA extracted 
from the fragments of the abdominal aorta with a slight atherosclerotic 
lesion (below) and a significant defect caused by atherosclerosis (top).
The results obtained testify to the activation of the 
9-desaturase, which catalyzes the formation of the MUFA from 
the saturated FA and participates in the regulation of the response 
to environmental condition changes by maintaining the fluidity 
of the cell membranes. The presence of a sufficient amount of 
the PUFA in the food is known to inhibit the expression of the 
9-desaturase 11]. However, it is known that the FA are synthesized 
with the participation of fatty acid synthase (FAS) leading to 
the formation of palmitic acid [12]. When the FAS activity is 
normal, a significant part of the palmitic acid is converted into 
stearic and arachidic acids. The over-expression of the enzyme 
is accompanied by increasing the palmitic acid content relative 
to the stearic acid [11]. It is shown that this process is always 
accompanied by the active proliferation of the tumor cells while 
an inhibition of the FAS (for example, with PUFA) leads to its 
cessation [11,13]. The decrease in the palmitic acid by 15.0%, 
stearic acid by 40.2%, and arachidic acid by 38,3% in the aortas 
with advanced atherosclerotic lesions could be an indication of 
the increased activity of the FAS in the AP cells. The palmitic, 
and stearic and levels in the carotid arteries were reduced almost 
to one magnitude, relative to the control. 
Patients with CHD and atherosclerosis showed a 
significant change in the FA composition of the plasma lipids 
when compared with healthy individuals (Table 2). The fraction 
of the saturated FA, such as myristic, palmitic and stearic acids 
significantly increased. The PUFA content due to the linoleic 
acid was significantly reduced in the patients of the experimental 
group.  Herewith,  an  increase  in  the  endogenous  dihomo-γ-
linolenic acid was noted. It is known that the synthesis of this 
acid is activated under the conditions of a dietary deficit of 
PUFA. 
The data obtained about the participation of the linoleic 
acid  in  atherogenesis  are  confirmed  by  the  analysis  of  the 
postmortem blood plasma samples. In cases when the abdominal 
aorta had significant atherosclerotic lesions, the linoleic acid 
level was only 15.87 ± 1.92%.   However, the content of the 
linoleic acid was 21.92 ± 2.75% (p<0.05), when only the small 
atheromas were present.
 According to the statement mentioned prior, it can 
be  assumed  that  the  deficit  of  linoleic  acid  identified  in  the 
blood plasma in atherosclerosis patients may be the factor 
that stimulates the expression of the desaturases in the smooth 
muscle cells (SMC) against the background of high activity of 
the FAS, which ultimately promotes the myocyte proliferation. 
It should be noted that the relative monounsaturated oleic 
acid levels in the abdominal aortas of the rats (animals resistant 
to the development of atherosclerosis) is lower (32.9±1.81%, 
p<0.05) than that in humans [9]. Besides, the saturated palmitic 
acid level in the abdominal aortas of rats compared with the 
human abdominal aorta is higher (34.09±2.79%, p<0.05). While 
the relative arachidonic PUFA level (11.55±1.01%, p<0.001) in 
the rat plasma is higher, and the relative level of endogenous 
dihomo-γ-linolenic PUFA (0.47±0.07%, p<0.001) is lower than 
those in healthy human subjects. Thus, the low level of the 
monounsaturated oleic acid (lower than in humans) may be due 
to the high content of arachidonic PUFA in rat plasma.
A significant decrease in the relative level of the linoleic 
acid in the plasma without a significant change in the level of 
the other essential FA can be explained as follows. It could be 
that the absorption of free FA and monoglycerides formed after 
influence of the pancreatic lipase free FA (mostly saturated) are 
vigorously absorbed by the mucosal cells of the small intestine 
[9]. In this case, the monoglycerides containing considerable 
amounts of the linoleic acid are less absorbed than in a healthy 
organism. Herewith, the rate of absorption of the other PUFA 
contained in the phospholipids and cholesterol esters is not 
changed, and therefore, the levels of these acids in the plasma 
lipids do not deviate from the normal values.    
A study of the correlation between the levels of the 
individual fatty acids has revealed a close negative correlation 
between the relative content of the palmitic acid and linoleic acid 
of the plasma lipids in patients with CHD (r=-0.87, p<0.001) 
and that of the control group (r=-0.80, p<0.001). Moreover, the 
Table 2  
The fatty acid composition of the plasma lipids in CHD and 
atherosclerosis                                                                                                                                        
Fatty acids
(wt% of the total FA) Control, % Experiment, %
Myristic 0.67±0.12 1.29±0.31*
Palmitoleic 1.62±0.31 1.52±0.39
Palmitic 26.81±1.64 31.72±1.05*
Linoleic 30.38±2.35 20.65±2.26*
Oleic 16.73±1.28 16.61±1.09
Stearic 12.02±0.70 14.51±0.75*
Arachidonic 6.04±0.59 6.80±0.51
Dihomo-γ-linolenic  1.20±0.18 1.91±0.26*
Docosahexaenoic 2.10±0.38 2.55±0.28
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average negative correlations between the oleic and stearic acids 
were marked in the experimental and control groups (r=-0.59, 
p<0.05 and r=-0.53, p<0.05). 
In patients with CHD and atherosclerosis, the correlations 
between the individual fatty acids of the plasma lipids show a 
more complex characteristic. They showed a positive correlation 
between the stearic and linoleic acids (r=0.45, p<0.1), as well 
as a strong positive correlation between the palmitic and oleic 
acids (r=0.90, p<0.001). The correlation between the palmitic 
and stearic acids was negative (r=-0.62, p<0.05), although the 
levels of both saturated fatty acids were significantly increased. 
A strong negative correlation was observed between the linoleic 
and oleic acid levels(r=-0.92, p<0.001).
The increase in the proportion of phospholipids [5] with 
a high content of palmitic, stearic and linoleic acids against the 
triglycerides containing more palmitic and oleic acids than the 
linoleic acid may be a reason to change the correlations between 
the FA of the plasma lipids [14]. 
It should be noted that the balance of the FA in large AP 
is largely similar to the ratio of the FA in the same blood vessels 
with a normal texture (Table 3), and is significantly different 
from the spectrum of the FA of the plasma lipids (especially of 
healthy individuals).
Figure 2.
Spectrum of the FA: (a) - the part of the abdominal aorta with a normal texture; 
(b) - AP, (c) - BP of the same dead body, (d) - BP of a healthy individual. 
However, this indicates the presence of an active metabolism 
of the cellular elements of the AP directed toward maintaining 
homeostasis, while on the other hand this indicates that most 
part of the fatty acids of the AP are formed by the enzymatic 
processes in the SMC and that this is not the result of their intake 
from the blood flow (Fig. 2).
Conclusion
Based on our data, the following conclusions can be 
drawn.  Reduction in the relative content of the arachidonic 
acid in the intact common carotid arteries compared with that 
of the postmortem material of the abdominal aortas (regardless 
of the degree of atherosclerotic lesions) indicates their lower 
susceptibility to the effects of the reactive oxygen species. In 
the case of a significant atherosclerotic lesion of the abdominal 
aorta, the ratio of the saturated FA to the MUFA with the same 
number of carbon atoms is reduced in the abdominal aortas and 
the corresponding common carotid arteries, which indicates 
the increased activity of cellular desaturases. When there are 
advanced atherosclerotic lesions, a more significant reduction 
in the relative levels of stearic and arachidic saturated FA, when 
compared with the saturated palmitic acid, may indicate the 
activation of FAS synthesis. The FA balance from the large AP 
resembles the ratio of the FA in the fragments of the same vessels 
with normal consistency and is significantly different from the 
spectrum of FA in blood plasma of both healthy individuals as 
well as those with severe atherosclerotic process.These data 
indicate that the origin of the FA of the AP may be a result of the 
synthetic processes in the plaque cells. Blood plasma in patients 
with atherosclerosis and myocardial ischemia is characterized 
by an increase in the relative level of the saturated FA and a 
reduction in the linoleic PUFA. This can lead to increased levels 
of MUFA in the arterial vessels by the activation of the cellular 
desaturases. Evidence of this can also be seen as an increase in 
the fraction of the dihomo-γ-linolenic acid in the blood plasma.
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